Palleon Pharmaceuticals
Latest round
- Series B
Last raised
- Sep 2020
Total raised
- $121M
Investors
- 7
About Palleon Pharmaceuticals
Palleon Pharmaceuticals Inc.Founded in 2016 and headquartered in Waltham, US, Palleon Pharmaceuticals Inc. specializes in glycan editing therapies. The company has pivoted its focus towards addressing significant unmet medical needs in oncology and immunology.830 mn.Palleon Pharmaceuticals specializes in innovative therapies centered around glycan editing, targeting cancer and autoimmune diseases. The company focuses on utilizing advanced glycobiology techniques to modify glycan structures on cell surfaces, enhancing immune responses and improving treatment efficacy for patients with various malignancies and autoimmune conditions.Palleon Pharmaceuticals generates revenue through strategic partnerships and collaborations with pharmaceutical companies and research organizations. The company engages in licensing agreements that allow partners to access its glycan editing technologies for development into commercial therapies. Revenue transactions typically occur on a B2B basis, with partners paying for licenses or development services, often including milestone payments tied to the progress of clinical trials. The company intends to expand its market presence into Europe and Asia by the end of 2023, targeting regions with high demand for next-generation treatments.
Who invested in Palleon Pharmaceuticals
7 investors across 2 rounds
See all investors in Palleon Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Palleon Pharmaceuticals
Who invested in Palleon Pharmaceuticals?
Palleon Pharmaceuticals has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Palleon Pharmaceuticals raised?
Palleon Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Palleon Pharmaceuticals last raise money?
Palleon Pharmaceuticals's most recent round on record is a Series B, in Sep 2020.
What does Palleon Pharmaceuticals do?
Palleon Pharmaceuticals is a biotechnology company.
Where is Palleon Pharmaceuticals headquartered?
Palleon Pharmaceuticals is headquartered in Waltham, US.
Which VCs invest in companies like Palleon Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Palleon Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Palleon Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.